STERIS (NYSE:STE) has launched a new room biodecontamination device aimed at life sciences customers such as animal research labs and biotechnology companies.
Mentor, Ohio-based STERIS’ new device, called the VHP Victory Room Biodecontamination Unit, uses dry, vaporized hydrogen peroxide to sterilize a room as well as the equipment in it.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A customer might use the decontamination device, for example, to sterilize a room and equipment after a virus outbreak among research mice or to decommission a research facility, said Art Papineau, a product manager with STERIS.
“As STERIS’ process [uses] a dry vapor, it is highly compatible with most materials in these spaces and naturally breaks down into water and oxygen, rendering it a very green process,” Papineau said.
STERIS has received several regulatory clearances from the U.S. Food and Drug Administration recently, such as 510(k) clearances for a software modification and an accessory part for its System 1E liquid chemical sterilization system.
